David E. Magee

1.6k citations

17 papers · 1.3k indexed · 1 hit paper · h-index 13

Impact in

Genetics top 2%
- Estrogen and related hormone effects
Orthopedics and Sports Medicine top 5%
- Bone health and osteoporosis research

Papers in ⓘ

Toxicology 2
- Bioactive Compounds and Antitumor Agents 2
Genetics 13
- Estrogen and related hormone effects 13

Co-authors: Masahiko Sato (4 shared papers)Ellen R. Rowley (6 shared papers)Raymond A. Bendele (1 shared paper)William R. Bensch (1 shared paper)George J. Cullinan (1 shared paper)Raymond F. Kauffman (1 shared paper)A Bekele (1 shared paper)Larry J. Black (1 shared paper)
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Endocrinology (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Calcified Tissue International (1 paper)
Partner nations: United States

In The Last Decade

David E. Magee

17 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. 1994 · 506 citations

Peers

Countries citing papers authored by David E. Magee

Since Specialization

Citations

This map shows the geographic impact of David E. Magee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Magee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Magee more than expected).

Fields of papers citing papers by David E. Magee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Magee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Magee. The network helps show where David E. Magee may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Magee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Magee Line = papers co-authored together David E. Magee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. Journal of Clinical Investigation ·Larry J. Black, Masahiko Sato, Ellen R. Rowley, David E. Magee, A Bekele, D. Clive Williams, George J. Cullinan, Raymond A. Bendele, Raymond F. Kauffman, William R. Bensch Hit paper breakdown →	1994	506
2	Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene Journal of Medicinal Chemistry ·Timothy A. Grese, Stephen Cho, Don R. Finley, Alexander G. Godfrey, Charles D. Jones, Charles W. Lugar, Michael J. Martin, Ken Matsumoto, Lewis D. Pennington, Mark A. Winter, Mary D. Adrian, Harlan W. Cole, David E. Magee, Diane L. Phillips, Ellen R. Rowley, Lorri L. Short, Andrew L. Glasebrook, Henry U. Bryant	1997	152
3	Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat The Journal of Steroid Biochemistry and Molecular Biology ·Jeffrey A. Dodge, Andrew L. Glasebrook, David E. Magee, David L. Phillips, Masahiko Sato, Lorri L. Short, Henry U. Bryant	1996	123
4	Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators Journal of Medicinal Chemistry ·Timothy A. Grese, Lewis D. Pennington, James P. Sluka, Mary D. Adrian, Harlan W. Cole, Tina R. Fuson, David E. Magee, Diane L. Phillips, Ellen R. Rowley, Pamela K. Shetler, Lorri L. Short, Murali Venugopalan, Na Yang, Masahiko Sato, Andrew L. Glasebrook, Henry U. Bryant	1998	118
5	Dual-energy X-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats Journal of Bone and Mineral Research ·Masahiko Sato, Cindy McClintock, John Kim, Charles H. Turner, Henry U. Bryant, David E. Magee, Charles W. Slemenda	1994	91
6	The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology ·Glenda L. Evans, (unknown), David E. Magee, Masahiko Sato, Russell T. Turner	1994	78
7	Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor Annals of the New York Academy of Sciences ·Robin Fuchs‐Young, A. L. GLASEBROOK, Lorri L. Short, Michael W. Draper, Marian K. Rippy, Harlan W. Cole, David E. Magee, John D. Termine, H.U. Bryant	1995	70
8	Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. Endocrinology ·Glenda L. Evans, H.U. Bryant, David E. Magee, Russell T. Turner	1996	60
9	Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rat Calcified Tissue International ·Roger E. Roudebush, David E. Magee, D. N. Benslay, A.M. Bendele, Henry U. Bryant	1993	31
10	Clomiphene Prevents Cancellous Bone Loss from Tibia of Ovariectomized Rats Endocrinology ·Maritza A. Jimenez, David E. Magee, H.U. Bryant, Russell T. Turner	1997	30
11	Effects of Prolonged Ethinyl Estradiol Treatment on Calcium Channel Binding and In Vivo Calcium-Mediated Hemodynamic Responses in Ovariectomized Rats Journal of Pharmacology and Experimental Therapeutics ·Nancy Bowling, William E. Bloomquist, Marlene L. Cohen, Henry U. Bryant, Harlan W. Cole, David E. Magee, Ellen R. Rowley, Chris J. Vlahos	1997	18
12	Benzopyran selective estrogen receptor modulators (SERMs): Pharmacological effects and structural correlation with raloxifene Bioorganic & Medicinal Chemistry Letters ·Timothy A. Grese, James P. Sluka, Henry U. Bryant, Harlan W. Cole, John R. Kim, David E. Magee, Ellen R. Rowley, Masahiko Sato	1996	14
13	Serotonin-induced paw edema in the rat: Pharmacological profile General Pharmacology The Vascular System ·Harlan W. Cole, Charles Eric Brown, David E. Magee, Christopher M. Magee, Roger E. Roudebush, Henry U. Bryant	1995	14
14	Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic. Molecular Pharmacology ·D L Saussy, Dale E. Mais, Gregory P. Dubé, David E. Magee, K Brune, W L Kurtz, C. M. Williams	1991	11
15	B-Ring unsaturated estrogens: biological evaluation of 17α-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens Bioorganic & Medicinal Chemistry Letters ·Charles W. Lugar, David E. Magee, Mary D. Adrian, Pamela K. Shetler, Henry U. Bryant, Jeffrey A. Dodge	2003	10
16	Synthesis and pharmacology of 2-alkyl raloxifene analogs Bioorganic & Medicinal Chemistry Letters ·Timothy A. Grese, Stephen Cho, Henry U. Bryant, Harlan W. Cole, Andrew L. Glasebrook, David E. Magee, Diane L. Phillips, Ellen R. Rowley, Lorri L. Short	1996	10
17	Conversion of the phytoestrogen coumestrol into a selective estrogen receptor modulator (SERM) by attachment of an amine-containing sidechain Bioorganic & Medicinal Chemistry Letters ·Timothy A. Grese, Harlan W. Cole, David E. Magee, Diane L. Phillips, Pam K. Shetler, Lorri L. Short, A. L. GLASEBROOK, Henry U. Bryant	1996	5

About David E. Magee

David E. Magee is a scholar working on Toxicology, Genetics, Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Reproductive Medicine, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (13 papers), Bone health and osteoporosis research (4 papers), Menopause: Health Impacts and Treatments (4 papers), Endometriosis Research and Treatment (3 papers), Inflammatory mediators and NSAID effects (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Genetics (877 citations), Orthopedics and Sports Medicine (221 citations), Toxicology (78 citations), Endocrinology, Diabetes and Metabolism (340 citations) and Reproductive Medicine (114 citations). David E. Magee has collaborated with scholars based in United States. Frequent co-authors include Masahiko Sato, Ellen R. Rowley, Raymond A. Bendele, William R. Bensch, George J. Cullinan, Raymond F. Kauffman, A Bekele, Larry J. Black, D. Clive Williams and Lorri L. Short. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Endocrinology, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Calcified Tissue International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact